XML 36 R24.htm IDEA: XBRL DOCUMENT v3.25.0.1
Earnings (Loss) Per Share
12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share

Note 13. Earnings Per Share

 

Basic earnings per share is calculated by dividing Net income by the weighted-average number of shares of the Company's common stock outstanding. Diluted earnings per share is similarly calculated, except that the calculation includes the dilutive effect of the assumed issuance of shares under stock-based compensation plans, unless the inclusion of such shares would have an anti-dilutive impact. As part of the AccuTrade Acquisition, the Company may pay up to $15.0 million of the contingent consideration in shares of the Company's common stock at a future date. Those potential shares have been excluded from the computations below because they are contingently issuable shares, and the contingency to which the issuance relates was not met at the end of the reporting period. The computation of Earnings per share is as follows (in thousands, except per share amounts):

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

Net income (1)

 

$

48,188

 

 

$

118,442

 

 

$

17,206

 

Basic weighted-average common shares outstanding

 

 

66,006

 

 

 

66,742

 

 

 

68,215

 

Effect of dilutive stock-based compensation awards (2)

 

 

1,381

 

 

 

1,485

 

 

 

1,434

 

Diluted weighted-average common shares outstanding

 

 

67,387

 

 

 

68,227

 

 

 

69,649

 

Earnings per share, basic (1)

 

$

0.73

 

 

$

1.77

 

 

$

0.25

 

Earnings per share, diluted (1)

 

 

0.72

 

 

 

1.74

 

 

 

0.25

 

 

(1)
During the year ended December 31, 2023 the Company released a significant portion of its valuation allowance for deferred tax assets that had been recorded as a result of the 2020 goodwill and indefinite-lived intangible asset impairments. For more information, see Note 14 (Income Taxes).

 

(2)
There were 31, 290 and 2,033 potential common shares excluded from diluted weighted-average common shares outstanding for the years ended December 31, 2024, 2023 and 2022, respectively, as their inclusion would have had an anti-dilutive effect.